297 related articles for article (PubMed ID: 37724299)
1. Nano drug delivery systems improve metastatic breast cancer therapy.
Zhu R; Lang T; Yin Q; Li Y
Med Rev (2021); 2021 Dec; 1(2):244-274. PubMed ID: 37724299
[TBL] [Abstract][Full Text] [Related]
2. Versatile biomimetic nanomedicine for treating cancer and inflammation disease.
Zhao Z; Wang D; Li Y
Med Rev (2021); 2023 Apr; 3(2):123-151. PubMed ID: 37724085
[TBL] [Abstract][Full Text] [Related]
3. Antitumor therapy for breast cancer: Focus on tumor-associated macrophages and nanosized drug delivery systems.
Zhan C; Jin Y; Xu X; Shao J; Jin C
Cancer Med; 2023 May; 12(10):11049-11072. PubMed ID: 36794651
[TBL] [Abstract][Full Text] [Related]
4. Rational Design of Nanotherapeutics Based on the Five Features Principle for Potent Elimination of Cancer Stem Cells.
Zhang Z; Deng Q; Xiao C; Li Z; Yang X
Acc Chem Res; 2022 Feb; 55(4):526-536. PubMed ID: 35077133
[TBL] [Abstract][Full Text] [Related]
5. Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review.
Khan MI; Hossain MI; Hossain MK; Rubel MHK; Hossain KM; Mahfuz AMUB; Anik MI
ACS Appl Bio Mater; 2022 Mar; 5(3):971-1012. PubMed ID: 35226465
[TBL] [Abstract][Full Text] [Related]
6. Stimuli-responsive and biomimetic delivery systems for sepsis and related complications.
Ismail EA; Devnarain N; Govender T; Omolo CA
J Control Release; 2022 Dec; 352():1048-1070. PubMed ID: 36372385
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in sono-photodynamic cancer therapy: From developed new sensitizers to nanotechnology-based efficacy-enhancing strategies.
Zheng Y; Ye J; Li Z; Chen H; Gao Y
Acta Pharm Sin B; 2021 Aug; 11(8):2197-2219. PubMed ID: 34522584
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances.
Jia Y; Chen S; Wang C; Sun T; Yang L
Front Bioeng Biotechnol; 2022; 10():990145. PubMed ID: 36091467
[TBL] [Abstract][Full Text] [Related]
9. Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases.
Deng Y; Zhang X; Shen H; He Q; Wu Z; Liao W; Yuan M
Front Bioeng Biotechnol; 2019; 7():489. PubMed ID: 32083068
[TBL] [Abstract][Full Text] [Related]
10. Strategies of overcoming the physiological barriers for tumor-targeted nano-sized drug delivery systems.
Pi Y; Zhou J; Wang J; Zhong J; Zhang L; Wang Y; Yu L; Yan Z
Curr Pharm Des; 2015; 21(42):6236-45. PubMed ID: 26503142
[TBL] [Abstract][Full Text] [Related]
11. Aggregation-induced emission (AIE) fluorophores as imaging tools to trace the biological fate of nano-based drug delivery systems.
Wang Y; Zhang Y; Wang J; Liang XJ
Adv Drug Deliv Rev; 2019 Mar; 143():161-176. PubMed ID: 30529308
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.
Urbanova M; Cihova M; Buocikova V; Slopovsky J; Dubovan P; Pindak D; Tomas M; García-Bermejo L; Rodríguez-Garrote M; Earl J; Kohl Y; Kataki A; Dusinska M; Sainz B; Smolkova B; Gabelova A
Biomed Pharmacother; 2023 Sep; 165():115179. PubMed ID: 37481927
[TBL] [Abstract][Full Text] [Related]
13. Current status of
Wang T; Zhang D; Sun D; Gu J
J Pharm Anal; 2020 Jun; 10(3):221-232. PubMed ID: 32612868
[TBL] [Abstract][Full Text] [Related]
14. Rational design of multimodal therapeutic nanosystems for effective inhibition of tumor growth and metastasis.
Wang F; Huang Q; Wang Y; Zhang W; Lin R; Yu Y; Shen Y; Cui H; Guo S
Acta Biomater; 2018 Sep; 77():240-254. PubMed ID: 30012354
[TBL] [Abstract][Full Text] [Related]
15. Redox-sensitive nanoscale drug delivery systems for cancer treatment.
Mirhadi E; Mashreghi M; Faal Maleki M; Alavizadeh SH; Arabi L; Badiee A; Jaafari MR
Int J Pharm; 2020 Nov; 589():119882. PubMed ID: 32941986
[TBL] [Abstract][Full Text] [Related]
16. Advances in the variations and biomedical applications of stimuli-responsive nanodrug delivery systems.
Gong Z; Peng S; Cao J; Tan H; Zhao H; Bai J
Nanotechnology; 2024 Jan; 35(13):. PubMed ID: 38198449
[TBL] [Abstract][Full Text] [Related]
17. A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment.
Zou T; Lu W; Mezhuev Y; Lan M; Li L; Liu F; Cai T; Wu X; Cai Y
Eur J Pharm Biopharm; 2021 Sep; 166():30-43. PubMed ID: 34098073
[TBL] [Abstract][Full Text] [Related]
18. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
[TBL] [Abstract][Full Text] [Related]
19. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
20. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.
Gu X; Gao Y; Wang P; Wang L; Peng H; He Y; Liu Y; Feng N
J Control Release; 2021 May; 333():374-390. PubMed ID: 33798666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
